Coloplast A/S - Q1 2024/25 Earnings Release - Invitation to conference call on 4 February 2025 at 11.00am CET
Werte in diesem Artikel
Tuesday, 4 February 2025 at 10.00 - 11.00am CET
In connection with the publication of Coloplast’s interim financial results for Q1 2024/25, to be released same day around 07.30am CET, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.
The webcast of the conference call will be available during and after the event.
Coloplast will be represented by:
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Aleksandra Dimovska - Vice President, Investor Relations
Simone Dyrby Helvind - Senior Manager, Investor Relations
Webcast
For participants who do not wish to actively participate in the Q&A session, please access the conference call as a webcast via the link below:
Access the webcast here
Dial-in details
To actively participate in the Q&A session, please sign up ahead of the conference call on the link below to receive an email with dial-in details.
Register for the conference call here
For more information, please contact:
Aleksandra Dimovska - Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458. E-mail: dkadim@coloplast.com
Simone Dyrby Helvind - Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2981. E-mail: dksdk@coloplast.com
Julie Isabella Sommer Müggler - Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161. E-mail: dkjusm@coloplast.com
Coloplast will be available on individual phone lines after the conference call for further questions.
Attachment
Ausgewählte Hebelprodukte auf Coloplast A-S (B)
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Coloplast A-S (B)
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Nachrichten zu Coloplast A-S (B)
Analysen zu Coloplast A-S (B)
Datum | Rating | Analyst | |
---|---|---|---|
04.12.2012 | Coloplast equal-weight | Morgan Stanley | |
04.07.2012 | Coloplast neutral | J.P. Morgan Cazenove | |
15.03.2012 | Coloplast sell | UBS AG | |
07.12.2011 | Coloplast buy | Société Générale Group S.A. (SG) |
Datum | Rating | Analyst | |
---|---|---|---|
07.12.2011 | Coloplast buy | Société Générale Group S.A. (SG) |
Datum | Rating | Analyst | |
---|---|---|---|
04.12.2012 | Coloplast equal-weight | Morgan Stanley | |
04.07.2012 | Coloplast neutral | J.P. Morgan Cazenove |
Datum | Rating | Analyst | |
---|---|---|---|
15.03.2012 | Coloplast sell | UBS AG |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Coloplast A-S (B) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen